Advertisement
Loading...

Abbisko Cayman Limited

2256.HKHKSE
Healthcare
Biotechnology
HK$9.52
HK$-0.23(-2.36%)
Hong Kong Market is Open • 11:20
Advertisement

Abbisko Cayman Limited Fundamental Analysis

Abbisko Cayman Limited (2256.HK) shows strong financial fundamentals with a PE ratio of 22.12, profit margin of 38.87%, and ROE of 11.49%. The company generates $0.6B in annual revenue with strong year-over-year growth of 25.44%.

Key Strengths

Operating Margin35.25%
Cash Position34.24%
PEG Ratio0.00
Current Ratio4.98

Areas of Concern

No major concerns flagged.
We analyze 2256.HK's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 75.4/100 based on profitability, valuation, growth, and balance sheet metrics. The B grade reflects solid fundamentals with room for improvement in valuation or growth.

Fundamental Health Score

B
75.4/100

We analyze 2256.HK's fundamental strength across five key dimensions:

Efficiency Score

Excellent

2256.HK demonstrates superior asset utilization.

ROA > 10%
10.17%

Valuation Score

Excellent

2256.HK trades at attractive valuation levels.

PE < 25
22.12
PEG Ratio < 2
0.00

Growth Score

Moderate

2256.HK shows steady but slowing expansion.

Revenue Growth > 5%
25.44%
EPS Growth > 10%
1.06%

Financial Health Score

Excellent

2256.HK maintains a strong and stable balance sheet.

Debt/Equity < 1
0.16
Current Ratio > 1
4.98

Profitability Score

Moderate

2256.HK maintains healthy but balanced margins.

ROE > 15%
11.49%
Net Margin ≥ 15%
38.87%
Positive Free Cash Flow
Yes

Key Financial Metrics

Is 2256.HK Expensive or Cheap?

P/E Ratio

2256.HK trades at 22.12 times earnings. This indicates a fair valuation.

22.12

PEG Ratio

When adjusting for growth, 2256.HK's PEG of 0.00 indicates potential undervaluation.

0.00

Price to Book

The market values Abbisko Cayman Limited at 2.75 times its book value. This may indicate undervaluation.

2.75

EV/EBITDA

Enterprise value stands at 26.17 times EBITDA. This signals the market has high growth expectations.

26.17

How Well Does 2256.HK Make Money?

Net Profit Margin

For every $100 in sales, Abbisko Cayman Limited keeps $38.87 as profit after all expenses.

38.87%

Operating Margin

Core operations generate 35.25 in profit for every $100 in revenue, before interest and taxes.

35.25%

ROE

Management delivers $11.49 in profit for every $100 of shareholder equity.

11.49%

ROA

Abbisko Cayman Limited generates $10.17 in profit for every $100 in assets, demonstrating efficient asset deployment.

10.17%

Following the Money - Real Cash Generation

Operating Cash Flow

Abbisko Cayman Limited generates strong operating cash flow of $222.72M, reflecting robust business health.

$222.72M

Free Cash Flow

Abbisko Cayman Limited generates strong free cash flow of $220.07M, providing ample flexibility for dividends, buybacks, or growth.

$220.07M

FCF Per Share

Each share generates $0.33 in free cash annually.

$0.33

FCF Yield

2256.HK converts 3.92% of its market value into free cash.

3.92%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

22.12

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

0.004

vs 25 benchmark

P/B Ratio

Price to book value ratio

2.75

vs 25 benchmark

P/S Ratio

Price to sales ratio

8.86

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.16

vs 25 benchmark

Current Ratio

Current assets to current liabilities

4.98

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

0.11

vs 25 benchmark

ROA

Return on assets percentage

0.10

vs 25 benchmark

ROCE

Return on capital employed

0.11

vs 25 benchmark

How 2256.HK Stacks Against Its Sector Peers

Metric2256.HK ValueSector AveragePerformance
P/E Ratio22.1228.32 Better (Cheaper)
ROE11.49%733.00% Weak
Net Margin38.87%-53055.00% (disorted) Strong
Debt/Equity0.160.38 Strong (Low Leverage)
Current Ratio4.984.03 Strong Liquidity
ROA10.17%-19488.00% (disorted) Strong

2256.HK outperforms its industry in 5 out of 6 key metrics, particularly excelling in Net Margin, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Abbisko Cayman Limited's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

12940.35%

Industry Style: Defensive, Growth, Innovation

High Growth

EPS CAGR

121.02%

Industry Style: Defensive, Growth, Innovation

High Growth

FCF CAGR

84.51%

Industry Style: Defensive, Growth, Innovation

High Growth

Fundamental Analysis FAQ